Controlling pertussis: how can we do it? A focus on immunization

References

• Zepp F, Heininger U, Mertsola J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis. 2011;11(7):557–570.
   PubMed Web of Science ®Google Scholar
• Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to bordetella pertussis and other bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326–382.
   PubMed Web of Science ®Google Scholar
• Skoff TH, Baumbach J, Cieslak PR. Tracking pertussis and evaluating control measures through enhanced pertussis surveillance, emerging infections program, United States. Emerg Infect Dis. 2015;21(9):1568–1573.
   PubMed Web of Science ®Google Scholar
• Rohani P, Zhong X, King AA. Contact network structure explains the changing epidemiology of pertussis. Science. 2010;330(6006):982–985.
   PubMed Web of Science ®Google Scholar
• Weerasinghe C, Fernandes A, Bagaria J. Pertussis: a cluster of linked cases in the United Kingdom, 2006. Euro Surveill. 2007;12(9):E5–E6.
   PubMedGoogle Scholar
• World Health Organization. Pertussis vaccines: WHO position paper – august 2015. Wkly Epidemiol Rec. 2015;90(35):433–460.
   PubMedGoogle Scholar
• Kretzschmar M, Teunis PFM, Pebody RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five european countries. PLoS Med. 2010;7(6):e1000291.
   PubMed Web of Science ®Google Scholar
• Heininger U, André P, Chlibek R, et al. Comparative epidemiologic characteristics of pertussis in 10 central and eastern European countries, 2000-2013. PLoS One. 2016;11(6):e0155949.
   PubMed Web of Science ®Google Scholar
• Cherry JD, Tan T, Wirsing von König C-H, et al. Clinical definitions of pertussis: summary of a global pertussis initiative roundtable meeting, february 2011. Clin Infect Dis. 2012;54(12):1756–1764.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Annual Epidemiological Report 2016 – Pertussis. 2016. [cited 2017 Jun 20]. Available from: http://ecdc.europa.eu/en/healthtopics/pertussis/Pages/Annual-epidemiological-report-2016.aspx
   Google Scholar
• Kilgore PE, Salim AM, Zervos MJ, et al. Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev. 2016;29(3):449–486.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Pertussis Surveillance Report 2008. 2010. [cited 2018 Jan 24]. Available from: https://ecdc.europa.eu/en/publications-data/pertussis-surveillance-report-2008
   Google Scholar
• Tozzi AE, Pandolfi E, Celentano LP, et al. Comparison of pertussis surveillance systems in Europe. Vaccine. 2007;25(2):291–297.
   PubMed Web of Science ®Google Scholar
• OECD. Child vaccination rates (indicator). 2018. [cited 2018 Jan 24]. Available from: https://data.oecd.org/healthcare/child-vaccination-rates.htm
   Google Scholar
• European Centre for Disease Prevention and Control. Vaccine Schedule - Recommended immunisations for pertussis. [cited 2017 Jun 20]. Available from: http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx
   Google Scholar
• Pichichero ME. Acellular pertussis vaccines. Drug Saf. 1996;15(5):311–324.
   PubMed Web of Science ®Google Scholar
• Zhang L, Prietsch Sílvio OM, Axelsson I, et al. Acellular vaccines for preventing whooping cough in children. Cochrane database of systematic reviews. UK: John Wiley & Sons, Ltd; 2014.
   Google Scholar
• Bisgard KM, Rhodes P, Connelly BL, et al. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998–2001. Pediatrics. 2005;116(2):e285–e294.
   PubMed Web of Science ®Google Scholar
• Hviid A, Stellfeld M, Andersen PH, et al. Impact of routine vaccination with a pertussis toxoid vaccine in Denmark. Vaccine. 2004;22(27):3530–3534.
   PubMed Web of Science ®Google Scholar
• Thierry-Carstensen B, Dalby T, Stevner MA, et al. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults—A review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine. 2013;31(45):5178–5191.
   PubMed Web of Science ®Google Scholar
• Taranger J, Trollfors B, Bergfors E, et al. Mass vaccination of children with pertussis toxoid—decreased incidence in both vaccinated and nonvaccinated persons. Clin Infect Dis. 2001;33(7):1004–1009.
   PubMed Web of Science ®Google Scholar
• Cherry JD. The history of pertussis (whooping cough); 1906–2015: facts, myths, and misconceptions. Curr Epidemiol Rep. 2015;2(2):120–130.
   Google Scholar
• Domenech de Cellès M, Magpantay FMG, King AA, et al. The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc Royal Soc B: Biol Sci. 2016;283(1822):1–10.
   PubMed Web of Science ®Google Scholar
• Althouse BM, Scarpino SV. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Med. 2015;13(1):146.
   PubMedGoogle Scholar
• Riolo MA, King AA, Rohani P. Can vaccine legacy explain the British pertussis resurgence? Vaccine. 2013;31(49):5903–5908.
   PubMed Web of Science ®Google Scholar
• Sealey KL, Belcher T, Preston A. Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence. Infection, Genet Evol. 2016;40:136–143.
   PubMed Web of Science ®Google Scholar
• Broutin H, Viboud C, Grenfell BT, et al. Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proc Royal Soc B: Biol Sci. 2010;277(1698):3239–3245.
   PubMed Web of Science ®Google Scholar
• Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infection, Genet Evol. 2010;10(1):36–49.
   PubMed Web of Science ®Google Scholar
• Fine P, Eames K, Heymann DL. “Herd immunity”: a rough guide. Clin Infect Dis. 2011;52(7):911–916.
   PubMed Web of Science ®Google Scholar
• Leask J, Willaby HW, Kaufman J. The big picture in addressing vaccine hesitancy. Hum Vaccin Immunother. 2014;10(9):2600–2602.
   PubMed Web of Science ®Google Scholar
• Thomson A, Watson M. Vaccine hesitancy: a vade mecum v1.0. Vaccine. 2016;34(17):1989–1992.
   PubMed Web of Science ®Google Scholar
• Maertens K, Braeckman T, Top G, et al. Maternal pertussis and influenza immunization coverage and attitude of health care workers towards these recommendations in Flanders, Belgium. Vaccine. 2016;34(47):5785–5791.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Immunization coverage. Fact Sheet. 2017 March. cited 2017 Jun 27; Available from: http://www.who.int/mediacentre/factsheets/fs378/en/
   Google Scholar
• Akmatov MK, Mikolajczyk RT. Timeliness of childhood vaccinations in 31 low and middle-income countries. J Epidemiol Community Health. 2012;66(7):e14–e.
   PubMed Web of Science ®Google Scholar
• Leask J, Kinnersley P, Jackson C, et al. Communicating with parents about vaccination: a framework for health professionals. BMC Pediatr. 2012;12:154.
   PubMed Web of Science ®Google Scholar
• Gust DA, Darling N, Kennedy A, et al. Parents with doubts about vaccines: which vaccines and reasons why. Pediatrics. 2008;122(4):718–725.
   PubMed Web of Science ®Google Scholar
• Dempsey AF, Schaffer S, Singer D, et al. Alternative vaccination schedule preferences among parents of young children. Pediatrics. 2011;128(5):848–856.
   PubMed Web of Science ®Google Scholar
• McCauley MM, Kennedy A, Basket M, et al. Exploring the choice to refuse or delay vaccines: a national survey of parents of 6- through 23-month-olds. Acad Pediatr. 2012;12(5):375–383.
   PubMed Web of Science ®Google Scholar
• Gangarosa EJ, Galazka AM, Wolfe CR, et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet. 1998;351(9099):356–361.
   PubMed Web of Science ®Google Scholar
• Dubé E, Gagnon D, MacDonald NE. Strategies intended to address vaccine hesitancy: review of published reviews. Vaccine. 2015;33(34):4191–4203.
   PubMed Web of Science ®Google Scholar
• Opel DJ, Heritage J, Taylor JA, et al. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132(6):1037–1046.
   PubMed Web of Science ®Google Scholar
• Wheelock A, Miraldo M, Thomson A, et al. Evaluating the importance of policy amenable factors in explaining influenza vaccination: a cross-sectional multinational study. BMJ Open. 2017;7(7):e014668.
   PubMed Web of Science ®Google Scholar
• Brewer NT, Hall ME, Malo TL, et al. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139(1). pii: e20161764.
   PubMed Web of Science ®Google Scholar
• Freed GL, Clark SJ, Butchart AT, et al. Sources and perceived credibility of vaccine-safety information for parents. Pediatrics. 2011;127(Supplement 1):S107–S12.
   PubMedGoogle Scholar
• Heininger U. An internet-based survey on parental attitudes towards immunization. Vaccine. 2006;24(37):6351–6355.
   PubMed Web of Science ®Google Scholar
• Marvel M, Epstein RM, Flowers K, et al. Soliciting the patient’s agenda: have we improved? JAMA. 1999;281(3):283–287.
   PubMed Web of Science ®Google Scholar
• Thomson A, Robinson K, Vallée-Tourangeau G. The 5As: a practical taxonomy for the determinants of vaccine uptake. Vaccine. 2016;34(8):1018–1024.
   PubMed Web of Science ®Google Scholar
• Pearce A, Marshall H, Bedford H, et al. Barriers to childhood immunisation: findings from the longitudinal study of Australian children. Vaccine. 2015;33(29):3377–3383.
   PubMed Web of Science ®Google Scholar
• Schwartz KL, Kwong JC, Deeks SL, et al. Effectiveness of pertussis vaccination and duration of immunity. CMAJ: Can Med Assoc J. 2016;188(16):E399–E406.
   PubMed Web of Science ®Google Scholar
• McGirr A, Fisman DN. Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics. 2015;135(2):331–343.
   PubMed Web of Science ®Google Scholar
• NHS Digital. NHS Immunisation Statistics, England - 2015-16. 2016 Sep 22. [cited 2018 Jan 25]. Available from: http://digital.nhs.uk/catalogue/PUB21651
   Google Scholar
• Klein NP, Bartlett J, Rowhani-Rahbar A, et al. Waning protection after fifth dose of acellular pertussis vaccine in children. New England J Med. 2012;367(11):1012–1019.
   PubMed Web of Science ®Google Scholar
• Thierry-Carstensen B, Jordan K, Uhlving HH, et al. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults. Vaccine. 2012;30(37):5464–5471.
   PubMed Web of Science ®Google Scholar
• Ward JI, Cherry JD, Chang S-J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. New England J Med. 2005;353(15):1555–1563.
   PubMed Web of Science ®Google Scholar
• Baxter R, Bartlett J, Rowhani-Rahbar A, et al. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ: Br Med J. 2013;347:f4249.
   PubMedGoogle Scholar
• Mertsola J, Van Der Meeren O, He Q, et al. Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults. Clin Infect Dis. 2010;51(6):656–662.
   PubMed Web of Science ®Google Scholar
• Maltezou HC, Wicker S, Borg M, et al. Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine. 2011;29(51):9557–9562.
   PubMed Web of Science ®Google Scholar
• Haviari S, Bénet T, Saadatian-Elahi M, et al. Vaccination of healthcare workers: a review. Hum Vaccin Immunother. 2015;11(11):2522–2537.
   PubMed Web of Science ®Google Scholar
• Quinn HE, Snelling TL, Habig A, et al. Parental Tdap boosters and infant pertussis: a case-control study. Pediatrics. 2014;134(4):713–720.
   PubMed Web of Science ®Google Scholar
• Carcione D, Regan AK, Tracey L, et al. The impact of parental postpartum pertussis vaccination on infection in infants: a population-based study of cocooning in Western Australia. Vaccine. 2015;33(42):5654–5661.
   PubMed Web of Science ®Google Scholar
• Healy CM, Rench MA, Wootton SH, et al. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatr Infect Dis J. 2015;34(1):22–26.
   PubMed Web of Science ®Google Scholar
• Urwyler P, Heininger U. Protecting newborns from pertussis - the challenge of complete cocooning. BMC Infect Dis. 2014;14:397.
   PubMed Web of Science ®Google Scholar
• Bohmer MM, Hellenbrand W, Matysiak-Klose D, et al. [Pertussis vaccination coverage among adults in Germany]. Dtsch Med Wochenschr. 2013;138(28–29):1451–1457.
   PubMed Web of Science ®Google Scholar
• Bodeker B, Remschmidt C, Muters S, et al. [Influenza, tetanus, and pertussis vaccination coverage among adults in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015;58(2):174–181.
   PubMed Web of Science ®Google Scholar
• Heininger U, Riffelmann M, Leineweber B, et al. Maternally derived antibodies against Bordetella pertussis antigens pertussis toxin and filamentous hemagglutinin in preterm and full term newborns. Pediatr Infect Dis J. 2009;28(5):443–445.
   PubMed Web of Science ®Google Scholar
• Dabrera G, Amirthalingam G, Andrews N, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012–2013. Clin Infect Dis. 2015;60(3):333–337.
   PubMed Web of Science ®Google Scholar
• Donegan K, King B, Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ. 2014;349:g4219.
   PubMed Web of Science ®Google Scholar
• Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384(9953):1521–1528.
   PubMed Web of Science ®Google Scholar
• Amirthalingam G, Campbell H, Ribeiro S, et al. Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction. Clin Infect Diseases. 2016;63(Suppl 4):S236–S43.
   PubMed Web of Science ®Google Scholar
• Ladhani SN, Andrews NJ, Southern J, et al. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator. Clin Infect Dis. 2015;61(11):1637–1644.
   PubMed Web of Science ®Google Scholar
• Maertens K, Caboré RN, Huygen K, et al. Pertussis vaccination during pregnancy in Belgium: follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age. Vaccine. 2016;34(31):3613–3619.
   PubMed Web of Science ®Google Scholar
• Agricola E, Gesualdo F, Alimenti L, et al. Knowledge attitude and practice toward pertussis vaccination during pregnancy among pregnant and postpartum Italian women. Hum Vaccin Immunother. 2016;12(8):1982–1988.
   PubMed Web of Science ®Google Scholar
• Public Health England. Pertussis vaccination programme for pregnant women update: vaccine coverage in England, January to March 2017. Health Protection Report: Public Health England, UK; 2017.
   Google Scholar
• MacDougall DM, Halperin BA, Langley JM, et al. Knowledge, attitudes, beliefs, and behaviors of pregnant women approached to participate in a Tdap maternal immunization randomized, controlled trial. Hum Vaccin Immunother. 2016;12(4):879–885.
   PubMed Web of Science ®Google Scholar
• Wiley KE, Massey PD, Cooper SC, et al. Pregnant women’s intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey. Vaccine. 2013;31(37):3972–3978.
   PubMed Web of Science ®Google Scholar
• Varan AK, Esteves-Jaramillo A, Richardson V, et al. Intention to accept Bordetella pertussis booster vaccine during pregnancy in Mexico City. Vaccine. 2014;32(7):785–792.
   PubMed Web of Science ®Google Scholar
• Wong CY, Thomas NJ, Clarke M, et al. Maternal uptake of pertussis cocooning strategy and other pregnancy related recommended immunizations. Hum Vaccin Immunother. 2015;11(5):1165–1172.
   PubMed Web of Science ®Google Scholar
• Gaudelus J, Martinot A, Denis F, et al. Vaccination of pregnant women in France. Med Mal Infect. 2016;46(8):424–428.
   PubMed Web of Science ®Google Scholar
• National Vaccine Advisory Committee. Overcoming barriers and identifying opportunities for developing maternal immunizations: recommendations from the national vaccine advisory committee. Public Health Rep. 2017;132(3):271–284.
   PubMed Web of Science ®Google Scholar
• Jackson LA, Yu O, Belongia EA, et al. Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a vaccine safety datalink study. BMC Infect Dis. 2009;9:165.
   PubMed Web of Science ®Google Scholar
• Halperin SA, Sweet L, Baxendale D, et al. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine? Pediatr Infect Dis J. 2006;25(3):195–200.
   PubMed Web of Science ®Google Scholar
• Talbot EA, Brown KH, Kirkland KB, et al. The safety of immunizing with tetanus–diphtheria–acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine. 2010;28(50):8001–8007.
   PubMed Web of Science ®Google Scholar
• Sukumaran L, McCarthy NL, Kharbanda EO, et al. Association of tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations. JAMA. 2015;314(15):1581–1587.
   PubMed Web of Science ®Google Scholar
• Morgan JL, Baggari SR, McIntire DD, et al. Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination. Obstetrics Gynecol. 2015;125(6):1433–1438.
   PubMed Web of Science ®Google Scholar
• Heininger U. Is there a need for a stand-alone acellular pertussis vaccine? Pediatr Infect Dis J. 2017 Nov 16. doi: 10.1097/INF.0000000000001767 [Epub ahead of print]
   PubMedGoogle Scholar
• Locht C, Mielcarek N. New pertussis vaccination approaches: en route to protect newborns? FEMS Immunol Med Microbiol. 2012;66(2):121–133.
   PubMedGoogle Scholar
• Thorstensson R, Trollfors B, Al-Tawil N, et al. A phase I clinical study of a live attenuated Bordetella pertussis vaccine–BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS One. 2014;9(1):e83449.
   PubMed Web of Science ®Google Scholar
• Frew PM, Lutz CS. Interventions to increase pediatric vaccine uptake: an overview of recent findings. Hum Vaccin Immunother. 2017;13(11):2503–2511.
   PubMed Web of Science ®Google Scholar